Efficacy and Safety of Intravenous Neridronic Acid in CRPS-I
Status:
Completed
Trial end date:
2016-11-01
Target enrollment:
Participant gender:
Summary
This clinical trial is being conducted to demonstrate the efficacy of neridronic acid in the
treatment of pain associated with complex regional pain syndrome type I (CRPS-I).
The trial is divided into 3 periods: a 60-day enrollment period, a 12-week trial period, and
an extended follow-up period with visits at Month 6, Month 9, and Month 12. The extended
follow-up period will be terminated for all participants after the last participant enrolled
completes their Month 6 visit (Visit 9). The double-blind will be maintained throughout the
12-week trial period and extended follow-up period.